Examples of potential side effects / adverse events include:
- Nausea (feeling sick)
An Adverse Event (AE), also known as a side effect, is an unwanted and unintended response in a patient, after receiving a medicinal product, that may or may not have been caused by treatment with this product. The information you provide helps to ensure the safety of our products and our patients.
Concerning Risdiplam (Evrysdi), Phesgo, Xofluza, Polivy, Roaccutane, Rozlytrek, Enspryng (Satralizumab), Ronapreve (Casirivimab + Imdevimab), GAVRETO (Pralsetinib), Lunsumio, Vabysmo:
▼ This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions.
If a pregnancy occurs while using Herceptin/PERJETA/Kadcyla/Phesgo or within 7 months following the last dose of Herceptin/Kadcyla/Phesgo or within 6 months following the last dose of PERJETA, please immediately report pregnancy to the local Roche Adverse Event line at +32 (0)2 525 82 99.
Additional information will be requested during a Herceptin/PERJETA//Phesgo/Kadcyla-exposed pregnancy and the first year of the infant's life. This will enable Roche to better understand the safety of Herceptin/PERJETA/Kadcyla/Phesgo and to provide appropriate information to health authorities, healthcare providers and patients.
Side effects may include (but are not limited to) symptoms like:
Please describe the adverse event as accurate as possible and provide as many details as possible, like for example: The [side effect] occured after taking [the product] on [date]. The [side effect] started on [date] and the patient was admitted into hospital. The [side effect] stopped on [date].
The pregnancy-related questions are meant to collect information about side effects and pregnancy. Thank you for contributing to making our products safer and more efficient.
Describe here the side effect, if this has resolved or is ongoing, how serious this is/was, the outcome and any further information that may be relevant both before, during and after the side effect occurred.
Information about the use of our medicines during pregnancy is valuable to us to increase knowledge of their safety and inform patients. Please note, patients should consult with their healthcare professional to be informed on the safety of taking a medicine during pregnancy.
To improve the safety of our medication, any information (at least 1 identifying detail) you can provide is very helpful. The data will be stored in accordance with data privacy regulations.
If you consent in contacting your healthcare professional, please provide details below.
You consent, by ticking the box above, to the processing of your data for the purposes of responding to your inquiry and in accordance with the Roche Privacy Notice for Pharmacovigilance, medical information and product complaints. If you do not consent to the data processing, we will not be able to reply to your message and kindly ask you to use other channels to contact us.
F. Hoffmann-La Roche Ltd ("Roche") has legal obligations to record and/or report adverse events. Therefore, for such purposes your data will be processed in accordance with specific GVP (pharmacovigilance) legislation, as further described in the Roche Privacy Notice for Pharmacovigilance, medical information and product complaints.
Roche will keep a record of the personal data that you provide for the purpose of responding to your inquiry, to follow up on such requests, to maintain the information in the Roche global pharmacovigilance database for reference and to comply with our legal and regulatory recording and reporting obligations. The retention time of data is in accordance with respective laws and regulations.
By including personal data of another data subject in the form, you represent the lawfulness of processing of such personal data.
By following this link, you are leaving Medical Information and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.